🔗 Permalink

Inventor profile of:

Peter Pushko

City:

Frederick, Maryland

Country:

United States

Published Applications:

Last publication date:

2025-07-03

Top Assignees for applications by Peter Pushko

The entities that hold a legal rights for patent applications filed by inventor Pushko Peter:

MEDIGEN, INC. 10 Frederick, MD United States
NOVAVAX, INC. 7 Gaithersburg, MD United States
The United States of America as Represented by the Secretary of the Army 5 Washington, DC United States
NOVAVAX, INC. 3 Rockville, MD United States
D4 Labs, LLC 2 Pacific Grove, CA United States
THE UAB RESEARCH FOUNDATION 1 Birmingham, AL United States
Emory University 1 Atlanta, GA United States
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL 1 Chapel Hill, NC United States

Recent patent applications by Pushko Peter

Peter Pushko from Frederick, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-07-03

US20250213671A1

Human necessities

NOVEL RNA AND DNA TECHNOLOGY FOR VACCINATION AGAINST ALPHAVIRUSES AND OTHER EMERGING AND EPIDEMIC VIRUSES

#2 | 2025-02-20

US20250057932A1

Human necessities

VACCINES AGAINST INFECTIOUS DISEASES CAUSED BY POSITIVE STRANDED RNA VIRUSES

#3 | 2024-08-22

US20240277832A1

Human necessities

DJUVANTED PROTEIN VACCINES COMPRISING MODIFIED FULL-LENGTH SPIKE PROTEIN OF SARS-COV-2 COMPOSITION AND METHODS OF USE

#4 | 2024-02-27

US18313017

Human necessities

Adjuvanted vaccines containing modified S1 Spike protein of SARS-CoV-2 variant C.1.2 for subcutaneous administration and methods of use

#5 | 2023-10-05

US20230310579A1

Human necessities

Recombinant bovine immunodeficiency virus-like particles comprising an influenza HA transmembrane domain and C-terminus

#6 | 2021-10-21

US20210322535A1

Human necessities

VACCINES AGAINST INFECTIOUS DISEASES CAUSED BY POSITIVE STRANDED RNA VIRUSES

#7 | 2019-10-17

US20190314482A1

Human necessities

Vaccines against infectious diseases caused by positive stranded RNA viruses

#8 | 2018-12-27

US20180369364A1

Human necessities

Recombinant bovine immunodeficiency virus gag virus-like particles containing influenza immunogens

#9 | 2018-08-30

US20180243404A1

Human necessities

iDNA vaccines and methods for using the same

#10 | 2016-03-17

US20160074500A1

Human necessities

Infectious DNA vaccines against chikungunya virus

#11 | 2015-12-17

US20150359872A1

Human necessities

Modified RSV F proteins and methods of their use

#12 | 2015-10-29

US20150307849A1

Chemistry; metallurgy

Highly efficient influenza matrix (M1) proteins

#13 | 2015-09-24

US20150266930A1

Chemistry; metallurgy

Modified RSV F proteins and methods of their use

#14 | 2015-09-24

US20150265698A1

Human necessities

Modified RSV F proteins and methods of their use

#15 | 2014-10-02

US20140294879A1

Chemistry; metallurgy

Modified RSV F proteins and methods of their use

#16 | 2014-06-26

US20140178430A1

Human necessities

IDNA vaccines and methods for using the same

#17 | 2013-02-28

US20130052225A1

Human necessities

Infectious DNA vaccines against chikungunya virus

#18 | 2013-02-14

US20130039938A1

Chemistry; metallurgy

Highly efficient influenza matrix (M1) proteins

#19 | 2011-10-06

US20110243989A1

Human necessities

IDNA vaccines and methods for using the same

#20 | 2010-12-30

US20100330122A1

Chemistry; metallurgy

VARICELLA ZOSTER VIRUS VIRUS-LIKE PARTICLES (VLPs) AND ANTIGENS

#21 | 2010-09-30

US20100247574A1

Chemistry; metallurgy

CHIMERIC NEWCASTLE DISEASE VIRUS VLPs

#22 | 2010-09-23

US20100239617A1

Human necessities

Modified RSV F proteins and methods of their use

#23 | 2010-08-05

US20100196419A1

Chemistry; metallurgy

Virus-like particles comprising chimeric human immunodeficiency virus (HIV)/mouse mammary tumor virus (MMTV) envelopes

#24 | 2010-07-22

US20100184192A1

Human necessities

Avian influenza chimeric VLPS

#25 | 2010-02-11

US20100035813A1

Chemistry; metallurgy

RECOMBINANT E-SELECTIN MADE IN INSECT CELLS

#26 | 2009-12-29

US10442502

Anthrax vaccine

#27 | 2008-05-20

US10405871

Vaccine against intoxication

#28 | 2007-10-18

US20070244043A1

Chemistry; metallurgy

Recombinant E-selectin made in insect cells

#29 | 2007-06-26

US10388327

Alphavirus RNA replicon systems

#30 | 2006-11-09

US20060251681A1

Chemistry; metallurgy

Methods for producing Marburg virus proteins

#31 | 2006-09-07

US20060198854A1

Chemistry; metallurgy

Vector platforms derived from the alphavirus vaccines

#32 | 2006-08-15

US10267322

Venezuelan equine encephalitis virus replicon encoding marburg virus proteins

#33 | 2006-01-10

US10696633

Ebola virion proteins expressed from venezuelan equine encephalitis (VEE) virus replicons

InventorID:

89273 ⎘